BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 31941527)

  • 1. Moderators of the effectiveness of an intervention to increase colorectal cancer screening through mailed fecal immunochemical test kits: results from a pragmatic randomized trial.
    O'Connor EA; Vollmer WM; Petrik AF; Green BB; Coronado GD
    Trials; 2020 Jan; 21(1):91. PubMed ID: 31941527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of a Mailed Colorectal Cancer Screening Outreach Program in Community Health Clinics: The STOP CRC Cluster Randomized Clinical Trial.
    Coronado GD; Petrik AF; Vollmer WM; Taplin SH; Keast EM; Fields S; Green BB
    JAMA Intern Med; 2018 Sep; 178(9):1174-1181. PubMed ID: 30083752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Patient Portal Messaging Before Mailing Fecal Immunochemical Test Kit on Colorectal Cancer Screening Rates: A Randomized Clinical Trial.
    Goshgarian G; Sorourdi C; May FP; Vangala S; Meshkat S; Roh L; Han MA; Croymans DM
    JAMA Netw Open; 2022 Feb; 5(2):e2146863. PubMed ID: 35119462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies and opportunities to STOP colon cancer in priority populations: pragmatic pilot study design and outcomes.
    Coronado GD; Vollmer WM; Petrik A; Aguirre J; Kapka T; Devoe J; Puro J; Miers T; Lembach J; Turner A; Sanchez J; Retecki S; Nelson C; Green B
    BMC Cancer; 2014 Feb; 14():55. PubMed ID: 24571550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using a continuum of hybrid effectiveness-implementation studies to put research-tested colorectal screening interventions into practice.
    Green BB; Coronado GD; Schwartz M; Coury J; Baldwin LM
    Implement Sci; 2019 May; 14(1):53. PubMed ID: 31142348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges in Reaching Medicaid and Medicare Enrollees in a Mailed Fecal Immunochemical Test Program.
    Green BB; West II; Baldwin LM; Schwartz MR; Coury J; Coronado GD
    J Community Health; 2020 Oct; 45(5):916-921. PubMed ID: 32219712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct-to-member mailed colorectal cancer screening outreach for Medicaid and Medicare enrollees: Implementation and effectiveness outcomes from the BeneFIT study.
    Coronado GD; Green BB; West II; Schwartz MR; Coury JK; Vollmer WM; Shapiro JA; Petrik AF; Baldwin LM
    Cancer; 2020 Feb; 126(3):540-548. PubMed ID: 31658375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies and Opportunities to STOP Colon Cancer in Priority Populations: design of a cluster-randomized pragmatic trial.
    Coronado GD; Vollmer WM; Petrik A; Taplin SH; Burdick TE; Meenan RT; Green BB
    Contemp Clin Trials; 2014 Jul; 38(2):344-9. PubMed ID: 24937017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized controlled trial of a multicomponent, targeted, low-literacy educational intervention compared with a nontargeted intervention to boost colorectal cancer screening with fecal immunochemical testing in community clinics.
    Davis SN; Christy SM; Chavarria EA; Abdulla R; Sutton SK; Schmidt AR; Vadaparampil ST; Quinn GP; Simmons VN; Ufondu CB; Ravindra C; Schultz I; Roetzheim RG; Shibata D; Meade CD; Gwede CK
    Cancer; 2017 Apr; 123(8):1390-1400. PubMed ID: 27906448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness and cost of multilayered colorectal cancer screening promotion interventions at federally qualified health centers in Washington State.
    Kemper KE; Glaze BL; Eastman CL; Waldron RC; Hoover S; Flagg T; Tangka FKL; Subramanian S
    Cancer; 2018 Nov; 124(21):4121-4129. PubMed ID: 30359468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health plan-based mailed fecal testing for colorectal cancer screening among dual-eligible Medicaid/Medicare enrollees: Outcomes of 2 program models.
    Baldwin LM; Coronado GD; West II; Schwartz MR; Meenan RT; Vollmer WM; Petrik AF; Shapiro JA; Kulkarni-Sharma YR; Green BB
    Cancer; 2022 Jan; 128(2):410-418. PubMed ID: 34586630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effectiveness of mailed reminders with and without fecal immunochemical tests for Medicaid beneficiaries at a large county health department: A randomized controlled trial.
    Brenner AT; Rhode J; Yang JY; Baker D; Drechsel R; Plescia M; Reuland DS; Wroth T; Wheeler SB
    Cancer; 2018 Aug; 124(16):3346-3354. PubMed ID: 30004577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uptake of colorectal cancer screening after mailed fecal immunochemical test (FIT) outreach in a newly eligible 45-49-year-old community health center population.
    O'Leary MC; Reuland DS; Correa SY; Moore AA; Malo TL; Tan X; Rohweder CL; Wheeler SB; Brenner AT
    Cancer Causes Control; 2023 Dec; 34(Suppl 1):125-133. PubMed ID: 37300632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First-year implementation of mailed FIT colorectal cancer screening programs in two Medicaid/Medicare health insurance plans: qualitative learnings from health plan quality improvement staff and leaders.
    Baldwin LM; Schneider JL; Schwartz M; Rivelli JS; Green BB; Petrik AF; Coronado GD
    BMC Health Serv Res; 2020 Feb; 20(1):132. PubMed ID: 32085767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective Cohort study of Predictors of Follow-Up Diagnostic Colonoscopy from a Pragmatic Trial of FIT Screening.
    O'Connor EA; Nielson CM; Petrik AF; Green BB; Coronado GD
    Sci Rep; 2020 Feb; 10(1):2441. PubMed ID: 32051454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors Influencing Implementation of a Colorectal Cancer Screening Improvement Program in Community Health Centers: an Applied Use of Configurational Comparative Methods.
    Petrik AF; Green B; Schneider J; Miech EJ; Coury J; Retecki S; Coronado GD
    J Gen Intern Med; 2020 Nov; 35(Suppl 2):815-822. PubMed ID: 33107003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Follow-up approaches to a health literacy intervention to increase colorectal cancer screening in rural community clinics: A randomized controlled trial.
    Arnold CL; Rademaker AW; Morris JD; Ferguson LA; Wiltz G; Davis TC
    Cancer; 2019 Oct; 125(20):3615-3622. PubMed ID: 31355924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Reminding Patients to Complete Fecal Immunochemical Testing: A Comparative Effectiveness Study of Automated and Live Approaches.
    Coronado GD; Rivelli JS; Fuoco MJ; Vollmer WM; Petrik AF; Keast E; Barker S; Topalanchik E; Jimenez R
    J Gen Intern Med; 2018 Jan; 33(1):72-78. PubMed ID: 29019046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Applying the Plan-Do-Study-Act (PDSA) approach to a large pragmatic study involving safety net clinics.
    Coury J; Schneider JL; Rivelli JS; Petrik AF; Seibel E; D'Agostini B; Taplin SH; Green BB; Coronado GD
    BMC Health Serv Res; 2017 Jun; 17(1):411. PubMed ID: 28629348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementing Mailed Colorectal Cancer Fecal Screening Tests in Real-World Primary Care Settings: Promising Implementation Practices and Opportunities for Improvement.
    Hohl SD; Maxwell AE; Sharma KP; Sun J; Vu TT; DeGroff A; Escoffery C; Schlueter D; Hannon PA
    Prev Sci; 2024 Apr; 25(Suppl 1):124-135. PubMed ID: 36952143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.